Delivery Order SPE2DE24D0013-SPE2D625F0RLM

The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,468.30 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, covers diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a task order under Cepheid's existing indefinite delivery vehicle (IDV) contracts with the Department of Veterans Affairs, which provide the company with ongoing authorization to supply molecular diagnostic systems, reagents, and assays across multiple federal healthcare networks.

Cepheid has established itself as a primary supplier of point-of-care and laboratory-based molecular diagnostic technologies to federal health agencies, with existing IDV contracts totaling over $35 million in potential value. The company's core offerings include GeneXpert diagnostic systems and associated test kits designed to detect infectious diseases across the VA's Veterans Integrated Service Networks and other Department of Defense health facilities. This delivery order exemplifies the ongoing federal procurement of diagnostic testing capabilities to support infectious disease detection and clinical laboratory operations within defense health systems.